Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03580408
Title Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation

Hodgkin's lymphoma


Nivolumab + Vinblastine


Age Groups: adult | senior
Covered Countries FRA | BEL

No variant requirements are available.